Literature DB >> 8045440

Immune response to specific molecules of the retina in proliferative vitreoretinal disorders.

S Grisanti1, K Heimann, P Wiedemann.   

Abstract

In recent years, several reports have contributed to a growing suspicion that there is immunologic involvement in proliferative intraocular disorders such as proliferative vitreoretinopathy and proliferative diabetic retinopathy. Immune privilege, as in the brain, ovary and testis, also exists in the eye. Therefore, immune responses to unique molecules of the eye, e.g. retinal S-antigen (S-Ag), which the immune system never learns to regard as "self", are possible. This study describes the presence of S-Ag, a major soluble photoreceptor protein involved in the visual transduction cascade, in pathological vitreous. We employed indirect immunoblotting, with human retina as substrate, and demonstrated the occurrence of antiretinal antibodies in the sera of a series of patients with proliferative vitreoretinal disorders. Immunoblot analysis of physiological retina and lyophilized S-Ag, revealed this protein as a target molecule of the immunological involvement of the retina. Further immunochemical investigation, however, must clarify whether this autoimmune reaction is the cause, a consequence, or an aggravating factor of the disease. As we come to understand the cellular and molecular mechanism, a new generation of therapeutic strategies may be envisioned.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8045440     DOI: 10.1007/bf00194480

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  27 in total

1.  [Immunomorphological study of the vitreous body and subretinal fluid in vitreoretinal proliferation].

Authors:  C Baudouin; F Brignole; J Bayle; D Fredj-Reygrobellet; P Lapalus; P Gastaud
Journal:  J Fr Ophtalmol       Date:  1991       Impact factor: 0.818

2.  HLA DR and DQ expression on human retinal pigment epithelial cells in vitro.

Authors:  C Baudouin; D Fredj-Reygrobellet; D Jambou; P Gastaud; P Lapalus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

3.  Evolution time and longitudinal studies of the anti-S-antigen antibody titers in retinitis pigmentosa.

Authors:  C D Heredia García; P A García Calderón
Journal:  Retina       Date:  1989       Impact factor: 4.256

4.  Are accessory molecules implicated in activation of T cells at the blood-retinal barrier?

Authors:  J Liversidge; J V Forrester
Journal:  Curr Eye Res       Date:  1990       Impact factor: 2.424

5.  Gel gradient electrophoresis, isoelectric focusing and two-dimensional techniques in horizontal, ultrathin polyacrylamide layers.

Authors:  A Görg; W Postel; R Westermeier; E Gianazza; P G Righetti
Journal:  J Biochem Biophys Methods       Date:  1980-11

6.  The pathophysiology of proliferative vitreoretinopathy.

Authors:  P Wiedemann; M Weller
Journal:  Acta Ophthalmol Suppl       Date:  1988

7.  Class II antigen expression in diabetic preretinal membranes.

Authors:  C Baudouin; W C Gordon; D Fredj-Reygrobellet; F Baudouin; G Peyman; P Gastaud; N G Bazan
Journal:  Am J Ophthalmol       Date:  1990-01-15       Impact factor: 5.258

8.  Cell-mediated immunity after retinal detachment as determined by lymphocyte stimulation.

Authors:  C J Brinkman; R M Broekhuyse
Journal:  Am J Ophthalmol       Date:  1978-08       Impact factor: 5.258

9.  Intercellular adhesion molecule-1 (ICAM-1) and leukocyte function-associated antigen-1 (LFA-1) expression in human epiretinal membranes.

Authors:  H P Heidenkummer; A Kampik
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

10.  The significance of complement in proliferative vitreoretinopathy.

Authors:  S Grisanti; P Wiedemann; M Weller; K Heimann; K Zilles
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-09       Impact factor: 4.799

View more
  7 in total

Review 1.  Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment.

Authors:  D G Charteris
Journal:  Br J Ophthalmol       Date:  1995-10       Impact factor: 4.638

2.  Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C-reactive protein concentration in diabetic retinopathy.

Authors:  Mariusz Nowak; Tomasz Wielkoszyński; Bogdan Marek; Beata Kos-Kudła; Elzbieta Swietochowska; Lucyna Siemińska; Jacek Karpe; Dariusz Kajdaniuk; Joanna Głogowska-Szelag; Katarzyna Nowak
Journal:  Clin Exp Med       Date:  2009-12-11       Impact factor: 3.984

3.  Blood serum levels of vascular cell adhesion molecule (sVCAM-1), intercellular adhesion molecule (sICAM-1) and endothelial leucocyte adhesion molecule-1 (ELAM-1) in diabetic retinopathy.

Authors:  Mariusz Nowak; Tomasz Wielkoszyński; Bogdan Marek; Beata Kos-Kudła; Elzbieta Swietochowska; Lucyna Siemińska; Dariusz Kajdaniuk; Joanna Głogowska-Szelag; Katarzyna Nowak
Journal:  Clin Exp Med       Date:  2008-09-13       Impact factor: 3.984

4.  Ocular pathogenesis and immune reaction after intravitreal dispase injection in mice.

Authors:  Juan Tan; Yaqin Liu; Wei Li; Qianying Gao
Journal:  Mol Vis       Date:  2012-04-07       Impact factor: 2.367

5.  Assessment of the innate and adaptive immune system in proliferative vitreoretinopathy.

Authors:  W Zhang; J Tan; Y Liu; W Li; Q Gao; P V Lehmann
Journal:  Eye (Lond)       Date:  2012-03-30       Impact factor: 3.775

6.  Influence of viral infection on expression of cell surface antigens in human retinal pigment epithelial cells.

Authors:  C Larcher; H Recheis; R Sgonc; W Göttinger; H P Huemer; E U Irschick
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-11       Impact factor: 3.117

7.  Susceptibility of human retinal pigment epithelial cells to different viruses.

Authors:  H P Huemer; C Larcher; W Kirchebner; J Klingenschmid; W Göttinger; E U Irschick
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-03       Impact factor: 3.117

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.